A Swiss study highlights the potential effectiveness of healthcare professionals in the face of aggressive industry marketing.

November 22, 2026

Par: National Committee Against Smoking

Dernière mise à jour: November 17, 2026

Temps de lecture: 8 minutes

Une étude suisse souligne l’efficacité possible des acteurs de santé face à un marketing industriel agressif

A study by three researchers from the University of Lausanne, Switzerland, examined the mobilization of Swiss public health organizations against Philip Morris International's IQOS flagship store project in Lausanne, launched in 2016. It shows how a coalition of stakeholders used political monitoring, independent research, and legal recourse to challenge a marketing strategy perceived as an attempt to renormalize tobacco use.[1], and calls for continuing and intensifying the fight to achieve further victories.

A Swiss market very favorable to the tobacco and nicotine industry

Switzerland generally serves as a testing ground for the international tobacco company Philip Morris, whose global operational headquarters are in Lausanne and research center in Neuchâtel. This was particularly true for IQOS, the heated tobacco product developed by the company. The country was one of the product's first markets after its launch in Japan in 2015. Philip Morris presented IQOS as an innovative alternative, promoted through a «harm reduction» narrative. Among the arguments put forward was the claim that the product did not produce smoke, thus downplaying its status as a «tobacco product,» even though it contains tobacco just like traditional cigarettes. This distinction, according to the study, allowed Philip Morris to benefit from less stringent regulations regarding health warnings and taxation, despite retail prices comparable to those of cigarettes, enabling the tobacco company to achieve exceptional profit margins.

Researchers and public health organizations quickly challenged this presentation. They argued that the aerosol from heated tobacco could contain harmful substances and pose health risks. They also pointed to the marketing that associated tobacco use with modernity, technology, and a lifestyle particularly emphasized by the tobacco company. The observed promotional campaigns included festivals, sponsorships, pop-up shops, and highly visible advertising. The study's authors believe that the early monitoring of these activities and the lessons learned from them, while Switzerland served as a test market, were not sufficiently disseminated.

The authors attribute this appeal of IQOS to a regulatory framework that has historically been less restrictive than in several European countries, particularly regarding advertising, promotion, and sponsorship. In this respect, the comparison between Switzerland and France highlights how the existence of protective rules in France, with clear and comprehensive legislation reinforced by case law established by civil society, has thus far prevented the development of this product. The strong presence of the tobacco industry in Switzerland, high purchasing power, and the appreciation of Swiss innovation have also contributed to the product's rollout. The country signed the WHO Framework Convention on Tobacco Control (FCTC) in 2004. but has still not ratified it. According to the authors, this situation has limited the implementation of more stringent tobacco control policies.

The «flagship store» controversy illustrates the long struggle of public health experts against industry marketing strategies.

The controversy intensified in 2016 when Philip Morris announced the opening of a 700-square-meter IQOS flagship store in a bustling area of Lausanne. The project combined a boutique, an exhibition space, a café-restaurant, and an event venue, and aimed to serve as a model for the product's global rollout.

For public health stakeholders, this location went beyond its commercial function: it blurred the lines between tobacco promotion, branding, and public space. They were particularly concerned about the normalization of tobacco use among young people and the lack of a smoking room, which suggested the product would be used indoors. The mobilization was organized around four key areas: political monitoring, dialogue with authorities, the production and dissemination of independent evidence, and legal challenges. Questions were raised in local and cantonal parliaments, while the Vaud Lung Association coordinated objections to the building permit. Researchers also submitted preliminary results to the authorities showing that the IQOS aerosol contained toxic substances comparable to those found in cigarette smoke. This collaboration between researchers, medical associations, prevention organizations, and institutional actors strengthened the credibility of the mobilization.

In 2017, authorities granted the building permit but prohibited the use of heated tobacco indoors, except in enclosed smoking rooms. This decision was based on the precautionary principle and the scientific data then available regarding the product's emissions. Research results formally published in 2017 confirmed the presence of toxic substances in IQOS aerosol. Philip Morris strongly criticized the study and unsuccessfully attempted to have it retracted, a move the authors link to past practices of the tobacco industry intimidating researchers. In 2018, before a court ruling could be issued, Philip Morris abandoned the flagship store project, citing purely commercial reasons. Public health organizations considered this withdrawal a victory, illustrating the ability of coordinated action to counter an elaborate marketing strategy.

In 2019, Philip Morris opened a smaller, 124-square-meter store in another part of Lausanne, complying with the indoor smoking ban. The authors believe that this outlet remained a visible advertisement, but with a reduced symbolic impact due to its less strategic location. Around the same time, new nicotine products such as e-cigarettes and nicotine pouches, which partially escape tobacco regulations because they do not contain tobacco or produce smoke, proliferated. Public health stakeholders seized upon this debate to advocate to cantonal authorities for a legislative framework encompassing all these products.

In 2024, cantonal and federal laws were revised with this in mind, with an exception concerning medical devices. Since 2025, advertising has been prohibited in shops accessible to minors in the canton of Vaud..

Recommendations combining monitoring of industrial practices, regulatory strengthening, independent research and cooperation among healthcare stakeholders

Researchers emphasize that the tobacco industry is constantly adapting its products and marketing strategies to exploit regulatory loopholes and regain social acceptance. The coalition of stakeholders therefore recommends continuous monitoring of industry innovations. It also stresses the need for broad, proactive, and robust legislation capable of covering emerging products with essential restrictive provisions. Independent research is presented as an essential counterpoint to industry narratives, which readily subsidize their own research, and as support for evidence-based policy decisions..

Finally, the authors conclude that coalitions combining scientific expertise, evidence-based advocacy, and political action are crucial for protecting public health. The Lausanne case, they argue, illustrates the possibility of influencing public policy even in a political environment dominated by the tobacco industry. This position enjoys popular support. According to a 2025 Unisanté survey conducted in French-speaking Switzerland, 90% of respondents believed that the Swiss state has a responsibility to better protect young people from the tobacco industry's strategies, while 88% felt that the economic interests of tobacco companies should not take precedence over public health..

©Generation Without Tobacco

AD


[1]Ballmer V., Zürcher K., Lebon L., IQOS "flagship store": a case study of public health advocacy against tobacco industry marketing in Switzerland, Swiss Med Wkly. 2026;156:5483, published on 16 November 2026, accessed on 17 November 2026

National Committee Against Smoking |

Ces actualités peuvent aussi vous intéresser